Navigation Links
BioPharm Systems to Host Webinar on an Add-On Solution for Oracle Clinical
Date:1/15/2013

San Mateo, CA (PRWEB) January 15, 2013

Who: Michelle Engler, develpoer of Accel-Copy, BioPharm Systems

What: Webinar: "A Peek Into a Must-Have Add-On Solution for Oracle Clinical"

Most of the companies that have seen Accel-Copy understand the value it provides and the productivity boost it gives to teams that work with Oracle Clinical. We invite you to experience it for yourself, too.

Please join BioPharm Systems’ Michelle Engler, the creator of Accel-Copy, for a free one-hour webinar, in which she will discuss and demonstrate the features and benefits of this time-saving solution meant for companies that:
-- Need to archive studies in their clinical systems production environment
-- Long for an easy way to create and refresh a training environment
-- Struggle with the complexities of migrating studies to a new environment
-- Desire the power of diagnosing production issues in a test environment without having to involve a database administrator

When: Wednesday, March 6, 2013 @:
8:00 a.m. US Pacific time
9:00 a.m. US Mountain time
10:00 a.m. US Central time
11:00 a.m. US Eastern time
16:00 UK time
17:00 Central European time

Webinar Information: To register for this complimentary webinar, go to: https://cc.readytalk.com/r/2v9j6mqme6w2

BioPharm Systems is a Gold level member of Oracle PartnerNetwork (OPN) and an Oracle Accelerate solution provider. The company has achieved Specializations in Oracle Argus Safety Suite, Oracle Life Sciences Data Hub, and Oracle Accelerate for Midsize Companies.

About Oracle PartnerNetwork
Oracle PartnerNetwork (OPN) Specialized is the latest version of Oracle's partner program that provides partners with tools to better develop, sell and implement Oracle solutions. OPN Specialized offers resources to train and support specialized knowledge of Oracle products and solutions and has evolved to recognize Oracle's growing product portfolio, partner base and business opportunity. Key to the latest enhancements to OPN is the ability for partners to differentiate through Specializations. Specializations are achieved through competency development, business results, expertise, and proven success. To find out more, visit oracle.com/partners.

About Oracle Accelerate
Oracle Accelerate provides simple to deploy, packaged, enterprise-class software solutions to growing midsize organizations through Oracle’s network of expert partners. Oracle Accelerate solutions enable growing midsize organizations to easily adopt Oracle's enterprise class software. Created by Oracle's expert partners, Oracle Accelerate solutions are simple to deploy, industry-specific packaged solutions, designed for fast time to benefit, which means getting the right solution in place quickly, inexpensively with a controlled scope and predictable returns. The best Oracle Accelerate Solutions are based on Oracle Business Accelerators, which are advanced implementation tools, created and maintained by Oracle. To find out more, visit oracle.com/accelerate.

About BioPharm Systems
BioPharm Systems (http://www.biopharm.com) is a global IT consulting and managed services provider that focuses on the life sciences industry. We have extensive experience in the implementation, integration, migration, upgrade, and hosting of the following Oracle clinical trial management, drug safety and pharmacovigilance, clinical data warehousing and analytics, clinical data management, and electronic data capture systems: Siebel Clinical, LabPas, Argus Safety Suite (Argus Safety, Argus Safety Japan, Affiliate, Interchange, Reconciliation, Dossier, Insight, and Perceptive), Adverse Event Reporting System (AERS), Empirica Signal, Empirica Topics, Life Sciences Data Hub (LSH), Clinical Development Analytics (CDA), Oracle Clinical, Remote Data Capture (RDC), and Thesaurus Management System (TMS).

Founded in 1995 and headquartered in California, BioPharm Systems has offices in the United States and the United Kingdom. To learn more about the company's products and services, please call +1 877 654 0033 (U.S.), +44 (0) 1865 910200 (U.K.), or e-mail info(at)biopharm(dot)com.

Trademarks

Oracle and Java are registered trademarks of Oracle and/or its affiliates.

North America Sales Contact:
Rod Roderick
rroderick(at)biopharm(dot)com
+1 877 654 0033

Europe/Middle East/Africa Sales Contact:
Rudolf Coetzee
rcoetzee(at)biopharm(dot)com
+44 (0) 1865 910200

Communications Contact:
Eugene Sefanov
esefanov(at)biopharm(dot)com
+1 617 795 2032

Twitter: twitter.com/BioPharmSystems
Facebook: facebook.com/BioPharmSystems
LinkedIn: linkedin.com/companies/biopharm-systems-inc
YouTube: youtube.com/user/BioPharmSystems
Google Plus: plus.google.com/104105608638786200757

Read the full story at http://www.prweb.com/releases/oracle-clinical-rdc-trial/software/prweb10208755.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioPharm Systems to Host Webinar on Self-service Account Management for Oracle Clinical, Remote Data Capture, and Thesaurus Management System
2. Array BioPharma Provides Updates On Clinical Data At The 2012 American Society Of Hematology Meeting
3. TransCelerate BioPharma Inc. Appoints Dalvir Gill as Chief Executive Officer
4. Array BioPharma Announces Exercise And Closing Of Underwriters Over-Allotment Option
5. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
6. PDL BioPharma to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
8. John A. Orwin Joins Array BioPharma Board Of Directors
9. Array BioPharma To Present Clinical Data At The 2012 ASH Meeting On ARRY-520, A KSP Inhibitor, And ARRY-614, A Dual p38/Tie2 Inhibitor
10. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
11. Array BioPharma to Hold Conference Call on Monday, November 5, 2012 to Discuss Submitted ASH Abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... AMRI, a global contract research, ... improve patient outcomes and quality of life, will now be offering its impurity ... to new regulatory requirements for all new drug products, including the finalization of ...
(Date:10/11/2017)... ... October 11, 2017 , ... Personal eye wash is a basic first aid supply for any ... So which eye do you rinse first if a dangerous substance enters both eyes? It’s ... Wash with its unique dual eye piece. , “Whether its dirt and debris, or ...
(Date:10/11/2017)... the Netherlands and LAGUNA HILLS, Calif. ... The Institute of Cancer Research, London ... use MMprofiler™ with SKY92, SkylineDx,s prognostic tool to risk-stratify patients ... trial known as MUK nine . The University of ... trial, which is partly funded by Myeloma UK, and ICR ...
(Date:10/10/2017)... DIEGO, CALIF. (PRWEB) , ... October 10, 2017 , ... ... as part of its corporate rebranding initiative announced today. The bold new look ... its reach, as the company moves into a significant growth period. , It will ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... April 11, 2017 No two people ... at the New York University Tandon School of ... have found that partial similarities between prints are ... in mobile phones and other electronic devices can ... The vulnerability lies in the fact that fingerprint-based ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
Breaking Biology News(10 mins):